Published in Eur J Neurosci on June 01, 2007
Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46
The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci (2011) 2.36
Relevance of animal models to human eating disorders and obesity. Psychopharmacology (Berl) (2008) 1.13
Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology (2012) 1.02
Analysis of the network of feeding neuroregulators using the Allen Brain Atlas. Neurosci Biobehav Rev (2008) 1.02
Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS One (2009) 1.01
Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology (Berl) (2008) 0.96
Complexity of neural mechanisms underlying overconsumption of sugar in scheduled feeding: involvement of opioids, orexin, oxytocin and NPY. Peptides (2008) 0.94
Mice lacking δ-opioid receptors resist the development of diet-induced obesity. FASEB J (2012) 0.93
Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition. Neuroscience (2009) 0.93
Effects of sex and COMT genotype on environmentally modulated cognitive control in mice. Proc Natl Acad Sci U S A (2012) 0.90
Methyl donor supplementation blocks the adverse effects of maternal high fat diet on offspring physiology. PLoS One (2013) 0.89
Mice lacking the G protein gamma3-subunit show resistance to opioids and diet induced obesity. Am J Physiol Regul Integr Comp Physiol (2009) 0.88
Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice. Eur J Pharmacol (2008) 0.88
Decreased consumption of sweet fluids in μ opioid receptor knockout mice: a microstructural analysis of licking behavior. Psychopharmacology (Berl) (2013) 0.82
Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. ILAR J (2012) 0.81
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice. Eur J Pharmacol (2009) 0.78
Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula. Neuroscience (2014) 0.78
Overlapping striatal sites mediate scopolamine-induced feeding suppression and mu-opioid-mediated hyperphagia in the rat. Psychopharmacology (Berl) (2013) 0.77
The use of animal models to decipher physiological and neurobiological alterations of anorexia nervosa patients. Front Endocrinol (Lausanne) (2015) 0.77
Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains. Psychopharmacology (Berl) (2014) 0.76
Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability. Soc Cogn Affect Neurosci (2016) 0.75
Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol Ther (2016) 0.75
Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell (2009) 3.61
Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med (2012) 2.82
Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science (2004) 2.76
Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med (2013) 2.66
Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46
Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol (2005) 2.32
Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A (2006) 1.95
Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain (2011) 1.90
Ketoconazole in Cushing's disease: is it worth a try? J Clin Endocrinol Metab (2014) 1.72
In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One (2009) 1.70
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol (2011) 1.69
The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci (2011) 1.60
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci (2003) 1.59
Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior. J Invest Dermatol (2006) 1.54
Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacol Ther (2007) 1.54
Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol (2004) 1.53
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg (2010) 1.48
Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest (2003) 1.40
Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence. J Pharmacol Exp Ther (2003) 1.32
Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci (2002) 1.32
Opioid receptors: distinct roles in mood disorders. Trends Neurosci (2012) 1.31
Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci (2003) 1.26
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab (2010) 1.24
Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci (2002) 1.24
Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance. J Neurosci (2010) 1.21
Identification of a novel family of G protein-coupled receptor associated sorting proteins. J Neurochem (2004) 1.20
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci U S A (2006) 1.19
Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci (2002) 1.19
The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci (2004) 1.19
Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res (2005) 1.17
Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci (2008) 1.14
Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab (2003) 1.14
Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry (2010) 1.14
Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol (2003) 1.13
The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol (2011) 1.13
Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet (2002) 1.13
Ligand-directed signalling within the opioid receptor family. Br J Pharmacol (2012) 1.13
Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci (2006) 1.12
Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes (2005) 1.12
Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res (2002) 1.10
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. J Clin Endocrinol Metab (2012) 1.10
Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry (2010) 1.09
Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation. Drug Saf (2008) 1.09
Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat Neurosci (2011) 1.08
Generation and characterization of Rgs4 mutant mice. Mol Cell Biol (2005) 1.08
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial. J Clin Endocrinol Metab (2013) 1.06
Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J Neurosci (2008) 1.03
Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J Pharmacol Exp Ther (2003) 1.01
Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS One (2009) 1.01
Induction of delta opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons. Mol Pharmacol (2005) 1.01
Ectopic ACTH syndrome in children and adolescents. J Clin Endocrinol Metab (2011) 1.01
Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. Eur J Pharmacol (2002) 1.00
Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav Brain Res (2006) 1.00
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct (2014) 1.00
The multiple facets of opioid receptor function: implications for addiction. Curr Opin Neurobiol (2013) 0.99
Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur J Neurosci (2003) 0.98
Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology (2007) 0.98
15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology (2013) 0.97
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. J Clin Endocrinol Metab (2014) 0.97
Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. Eur J Pharmacol (2007) 0.97
Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms. Neurobiol Learn Mem (2009) 0.97
Diagnosis and Differential Diagnosis of Cushing's Syndrome. N Engl J Med (2017) 0.97
Reduction of anxiety after restricted feeding in the rat: implication for eating disorders. Biol Psychiatry (2004) 0.97
Presynaptic delta opioid receptors regulate ethanol actions in central amygdala. J Pharmacol Exp Ther (2006) 0.96
Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology. Recent Dev Alcohol (2003) 0.95
Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology (2005) 0.95
Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. Eur J Neurosci (2003) 0.95
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol (2013) 0.94
Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat. Psychopharmacology (Berl) (2004) 0.94
Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor. J Neurochem (2006) 0.94
Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab (2008) 0.93
Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron (2007) 0.93
The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology (2007) 0.92
Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening. BMC Pharmacol (2003) 0.92
Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry (2007) 0.92
δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization. J Pharmacol Exp Ther (2012) 0.91
Delta opioid receptors in brain function and diseases. Pharmacol Ther (2013) 0.91
Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. Addict Biol (2011) 0.91
Mu-opioid receptors are involved in the tolerance to nicotine antinociception. J Neurochem (2006) 0.90
Mouse δ opioid receptors are located on presynaptic afferents to hippocampal pyramidal cells. Cell Mol Neurobiol (2012) 0.90
Probing opioid receptor interactions with azacycloalkane amino acids. Synthesis of a potent and selective ORL1 antagonist. J Med Chem (2002) 0.90
The second extracellular loop: a damper for G protein-coupled receptors? Nat Struct Mol Biol (2005) 0.90
Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. J Clin Endocrinol Metab (2004) 0.90
Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology (2008) 0.89
Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions. J Pharmacol Exp Ther (2008) 0.89
κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites. J Pharmacol Exp Ther (2013) 0.89
Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice. Neuropharmacology (2005) 0.89
Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice. Eur J Neurosci (2003) 0.89
Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome. J Clin Endocrinol Metab (2007) 0.89
Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions. J Pharmacol Exp Ther (2006) 0.88
Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. Neuropsychopharmacology (2007) 0.88
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up. Eur J Endocrinol (2011) 0.88
micro-Opioid receptor activation prevents acute hepatic inflammation and cell death. Gut (2007) 0.86
Mechanisms for the regulation of state changes in the central nervous system: an introduction. Ann N Y Acad Sci (2008) 0.86
Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS One (2012) 0.86
In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profile. J Neurosci (2012) 0.86
Endogenous nociceptin/orphanin-FQ in the dorsal hippocampus facilitates despair-related behavior. Hippocampus (2010) 0.85
Nitrous oxide (N2O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats. Neuropharmacology (2007) 0.85
Deletion of the mu opioid receptor results in impaired acquisition of Pavlovian context fear. Neurobiol Learn Mem (2005) 0.85
μ-Opioid receptors mediate the effects of chronic ethanol binge drinking on the hippocampal neurogenic niche. Addict Biol (2013) 0.85